Price T Rowe Associates Inc Acadia Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 621,010 shares of ACAD stock, worth $10.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

621,010

Previous 659,964 5.9%

Holding current value

$10.7 Million

Previous $10.2 Million 12.26%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$14.29 - $18.76 $556,652 - $730,777	-38,954 Reduced 5.9%	621,010 $11.4 Million
Q3 2024 Nov 14, 2024	SELL	$15.14 - $19.14 $3.94 Million - $4.98 Million	-260,122 Reduced 28.27%	659,964 $10.2 Million
Q2 2024 Aug 14, 2024	SELL	$14.62 - $18.42 $45 Million - $56.7 Million	-3,079,464 Reduced 77.0%	920,086 $15 Million
Q1 2024 May 15, 2024	SELL	$17.79 - $30.86 $21 Million - $36.4 Million	-1,178,959 Reduced 22.77%	3,999,550 $74 Million
Q4 2023 Feb 14, 2024	SELL	$20.78 - $31.77 $1.07 Million - $1.64 Million	-51,652 Reduced 0.99%	5,178,509 $162 Million
Q3 2023 Nov 14, 2023	SELL	$20.84 - $33.47 $16.3 Million - $26.2 Million	-783,753 Reduced 13.03%	5,230,161 $109 Million
Q2 2023 Aug 14, 2023	BUY	$17.8 - $25.65 $26 Million - $37.5 Million	1,463,008 Added 32.15%	6,013,914 $144 Million
Q1 2023 May 15, 2023	BUY	$16.32 - $20.92 $4.43 Million - $5.68 Million	271,652 Added 6.35%	4,550,906 $85.6 Million
Q4 2022 Feb 14, 2023	SELL	$14.2 - $18.63 $8.69 Million - $11.4 Million	-612,094 Reduced 12.51%	4,279,254 $68.1 Million
Q3 2022 Nov 14, 2022	BUY	$14.11 - $18.27 $2.79 Million - $3.61 Million	197,633 Added 4.21%	4,891,348 $80 Million
Q2 2022 Aug 15, 2022	SELL	$13.01 - $27.22 $3.71 Million - $7.76 Million	-285,221 Reduced 5.73%	4,693,715 $66.1 Million
Q1 2022 May 16, 2022	SELL	$20.94 - $27.5 $94.4 Million - $124 Million	-4,507,325 Reduced 47.51%	4,978,936 $121 Million
Q4 2021 Feb 14, 2022	BUY	$16.79 - $27.09 $901,908 - $1.46 Million	53,717 Added 0.57%	9,486,261 $221 Million
Q3 2021 Nov 15, 2021	SELL	$15.78 - $24.77 $12.1 Million - $19 Million	-766,287 Reduced 7.51%	9,432,544 $157 Million
Q2 2021 Aug 16, 2021	BUY	$19.4 - $27.42 $35.8 Million - $50.6 Million	1,844,820 Added 22.08%	10,198,831 $249 Million
Q1 2021 May 17, 2021	BUY	$25.02 - $54.99 $11.9 Million - $26.2 Million	476,186 Added 6.04%	8,354,011 $216 Million
Q4 2020 Feb 16, 2021	BUY	$41.04 - $56.79 $323 Million - $447 Million	7,877,825 New	7,877,825 $421 Million

Others Institutions Holding ACAD

# of Institutions

316

Shares Held

164M

Call Options Held

855K

Put Options Held

350K

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $2.78B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Acadia Pharmaceuticals Inc Transaction History